Fluid Dynamics in Man of an Intraperitoneal Drug Delivery Solution: 4% Icodextrin
Open Access
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis Ltd in Drug Delivery
- Vol. 8 (1), 9-12
- https://doi.org/10.1080/107175401300002694
Abstract
Interest in targeting drugs into the peritoneal cavity for intra-abdominal cancers or infections is undergoing a revival as recent clinical trials have demonstrated, not only a regional advantage in concentration of the active agent, but also improved long-term outcomes. Solutions currently used for intraperitoneal (IP) drug delivery have short residence times, however, which can limit the exposure of all areas of the peritoneum to the active agent. Icodextrin 4% solution was compared with saline and a glucose-based peritoneal dialysis solution in a clinical study of IP residence time. The study was carried out during the fortnightly rest phase in 9 patients undergoing 5-fluorouracil (5-Fu) IP treatment for colorectal cancer. The volume remaining in the peritoneal cavity was measured at 0, 12, 24, 48, 72, and 96 hr after an instillation of 2 liters of each fluid. Saline (n = 3 dwells) and glucose (n = 3 dwells) peritoneal dialysis solutions were almost fully absorbed by 24 hr, and the patients experienced discomfort when using these solutions. In contrast, icodextrin 4% solution (n = 188 dwells) maintained its instilled volume for up to 48 hr, and half the instilled volume remained after 72 and 96 hr. This result would allow extensive and prolonged coverage of the peritoneal surface. Icodextrin 4% solution may be an effective vehicle to deliver therapeutic agents into the peritoneal cavity.Keywords
This publication has 10 references indexed in Scilit:
- A Comparative Study of Intraperitoneal Carboplatin versus Intravenous Carboplatin with Intravenous Cyclophosphamide in Both Arms as Initial Chemotherapy for Stage III Ovarian CancerOncology, 1999
- Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinomaBritish Journal of Cancer, 1998
- Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDSAIDS, 1998
- Icodextrin Provides Long Dwell Peritoneal Dialysis and Maintenance of Intraperitoneal VolumeArtificial Organs, 1998
- Pharmacokinetic Problems in Peritoneal Drug Administration: Tissue Penetration and Surface ExposureJNCI Journal of the National Cancer Institute, 1997
- Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian CancerNew England Journal of Medicine, 1996
- Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solutionBritish Journal of Cancer, 1996
- Laparoscopically instilled fluid: the rate of absorption and the effects on patient discomfort and fluid balanceGynaecological Endoscopy, 1996
- Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinomaBritish Journal of Cancer, 1994
- Peritoneal lymphaticsPublished by Springer Science and Business Media LLC ,1994